News
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. Bridgewater ...
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...
Gilead Sciences, in partnership with the Global Fund, plans to supply a long-acting HIV prevention drug to low-income ...
1d
Zacks Investment Research on MSNGilead Sciences Rallies 27.2% in Six Months: Buy or Sell the Stock?Shares of Gilead Sciences, Inc. GILD have gained 27.2% in the past six months against the industry’s decline of 2.2%. The ...
Insights from strategists and analysts can greatly influence market sentiment and investment strategies. CNBC's Halftime ...
6don MSN
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company ...
1d
Zacks Investment Research on MSNHas Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year?Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Gilead Sciences (GILD) been one of those stocks this year? By taking a look at ...
As Gilead Sciences gets underway with the key launch of its twice-yearly pre-exposure prophylaxis (PrEP) HIV med, the company ...
Gilead Sciences Inc. closed 11.70% below its 52-week high of $119.96, which the company achieved on March 10th.
What kind of uptake can Gilead Sciences expect for its highly touted, long-acting HIV pre-exposure prophylaxis (PrEP) ...
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results